Recently, it has been proposed a model of pathogenesis of Langerhans cell Histiocytosis in which there is an initial inflammatory condition potentiated by Interleukin 1, continued by mutations of BRAF genes. The gene discussed is BRAF; the disease is Langerhans cell histiocytosis.